TECHLAB® Inc., a leader in infectious disease diagnostics, today announced it has partnered with the New River Valley COVID-19 Task Force to cost-effectively expand future COVID-19 testing capacity. Under this agreement, the New River Health District secures access to TECHLAB’s analyte-specific reagents (ASRs) for SARS-CoV-2 for as little as $7-9 per use.
“As a company founded and headquartered here in the New River Valley, we are proud to work closely with public health officials to provide a cost-effective and flexible option to increase their COVID-19 testing,” said Joel Herbein, Ph.D., Vice President of Scientific Affairs at TECHLAB. “Our analyte-specific reagents can be used now to maximize COVID-19 testing by any lab that is CLIA-certified to perform medium- and high-complexity testing. We are also incorporating our ASRs into 96-well and rapid antigen tests and plan to submit to the U.S. FDA for emergency use authorization.”